Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccination as Defense Against SARS-CoV-2 (BADAS)
NCT04348370Phase 4Completed
- Sponsor
- Texas A&M University
- Start
- Apr 2020
- Primary completion
- Apr 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by Texas A&M University. Started Apr 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04348370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04348370.